Pemvidutide

Pemvidutide is a dual agonist of GLP-1 and glucagon receptors, demonstrating significant reductions in body weight, hepatic fat, and blood lipids in preclinical studies. This profile makes it a promising candidate for research into metabolic diseases, including obesity and non-alcoholic steatohepatitis (NASH) .